Advertisement

Index by author

August 01, 2013; Volume 346,Issue 2

A

  1. Albert, Daniel H.

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  2. Alburges, Mario E.

    1. Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat
      Glen R. Hanson, Amanda J. Hoonakker, Christina M. Robson, Lisa M. McFadden, Paul S. Frankel and Mario E. Alburges
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 173-181; DOI: https://doi.org/10.1124/jpet.113.205310

  3. Alexander, Shawn T.

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  4. Andersson, Gunnar

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

  5. Andersson, Olga

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

  6. Aslanian, Sharon

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

B

  1. Badolo, Lassina

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

  2. Baruch, Amos

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  3. Behr, Jürgen

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

  4. Bell, Gregory

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  5. Belzer, Mathew

    1. Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2
      Mathew Belzer, Mark Morales, Bhumasamudram Jagadish, Eugene A. Mash and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 300-310; DOI: https://doi.org/10.1124/jpet.113.203257

  6. Bennacef, Idriss

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  7. Bradshaw, Curt W.

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  8. Bulgheroni, Elisabetta

    1. Selective and Potent Agonists and Antagonists for Investigating the Role of Mouse Oxytocin Receptors
      Marta Busnelli, Elisabetta Bulgheroni, Maurice Manning, Gunnar Kleinau and Bice Chini
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 318-327; DOI: https://doi.org/10.1124/jpet.113.202994

  9. Burnier, Michel

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

  10. Busnelli, Marta

    1. Selective and Potent Agonists and Antagonists for Investigating the Role of Mouse Oxytocin Receptors
      Marta Busnelli, Elisabetta Bulgheroni, Maurice Manning, Gunnar Kleinau and Bice Chini
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 318-327; DOI: https://doi.org/10.1124/jpet.113.202994

C

  1. Chapman, Mark

    1. Myocardial, Smooth Muscle, Nephron, and Collecting Duct Gene Targeting Reveals the Organ Sites of Endothelin A Receptor Antagonist Fluid Retention
      Deborah Stuart, Mark Chapman, Sara Rees, Stephanie Woodward and Donald E. Kohan
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 182-189; DOI: https://doi.org/10.1124/jpet.113.205286

  2. Chaturvedi, Prasoon

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  3. Chen, Gang

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  4. Chen, Lu

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  5. Chini, Bice

    1. Selective and Potent Agonists and Antagonists for Investigating the Role of Mouse Oxytocin Receptors
      Marta Busnelli, Elisabetta Bulgheroni, Maurice Manning, Gunnar Kleinau and Bice Chini
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 318-327; DOI: https://doi.org/10.1124/jpet.113.202994

  6. Comley, Robert A.

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

D

  1. Dong, Jin

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  2. Downey, Katherine J.

    1. Protective Properties of 2-Acetylcyclopentanone in a Mouse Model of Acetaminophen Hepatotoxicity
      Lihai Zhang, Terrence Gavin, Brian C. Geohagen, Qiang Liu, Katherine J. Downey and Richard M. LoPachin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 259-269; DOI: https://doi.org/10.1124/jpet.113.205435

  3. Dubrovskiy, Alex

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

E

  1. Evans, Erica K.

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

F

  1. Fang, San-Hua

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  2. Feldmann, Maria

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

  3. Foster, Kimberly A.

    1. Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor– Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway
      Daniel R. Premkumar, Esther P. Jane, Kimberly A. Foster and Ian F. Pollack
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 201-210; DOI: https://doi.org/10.1124/jpet.113.204743

  4. Fox, Gerard B.

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  5. Frankel, Paul S.

    1. Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat
      Glen R. Hanson, Amanda J. Hoonakker, Christina M. Robson, Lisa M. McFadden, Paul S. Frankel and Mario E. Alburges
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 173-181; DOI: https://doi.org/10.1124/jpet.113.205310

  6. Freed, Martin I.

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  7. Funk, Felix

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

G

  1. Gavin, Terrence

    1. Protective Properties of 2-Acetylcyclopentanone in a Mouse Model of Acetaminophen Hepatotoxicity
      Lihai Zhang, Terrence Gavin, Brian C. Geohagen, Qiang Liu, Katherine J. Downey and Richard M. LoPachin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 259-269; DOI: https://doi.org/10.1124/jpet.113.205435

  2. Geohagen, Brian C.

    1. Protective Properties of 2-Acetylcyclopentanone in a Mouse Model of Acetaminophen Hepatotoxicity
      Lihai Zhang, Terrence Gavin, Brian C. Geohagen, Qiang Liu, Katherine J. Downey and Richard M. LoPachin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 259-269; DOI: https://doi.org/10.1124/jpet.113.205435

  3. Gomeni, Roberto

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  4. Gray, Frank A.

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  5. Gunn, Roger N.

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

H

  1. Hansen, Steen Honoré

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

  2. Hanson, Glen R.

    1. Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat
      Glen R. Hanson, Amanda J. Hoonakker, Christina M. Robson, Lisa M. McFadden, Paul S. Frankel and Mario E. Alburges
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 173-181; DOI: https://doi.org/10.1124/jpet.113.205310

  3. Hegde, S. S.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

  4. Hellman, Karin

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

  5. Hoonakker, Amanda J.

    1. Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat
      Glen R. Hanson, Amanda J. Hoonakker, Christina M. Robson, Lisa M. McFadden, Paul S. Frankel and Mario E. Alburges
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 173-181; DOI: https://doi.org/10.1124/jpet.113.205310

  6. Huang, Jie

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  7. Hunter, Tom

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  8. Huyghe, Bernard

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

I

  1. Iavarone, Laura

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  2. Ishino, Tetsuya

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

J

  1. Jackson, Edwin K.

    1. In Vivo Cardiovascular Pharmacology of 2′,3′-cAMP, 2′-AMP, and 3′-AMP in the Rat
      Edwin K. Jackson and Zaichuan Mi
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 190-200; DOI: https://doi.org/10.1124/jpet.113.205757

  2. Jagadish, Bhumasamudram

    1. Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2
      Mathew Belzer, Mark Morales, Bhumasamudram Jagadish, Eugene A. Mash and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 300-310; DOI: https://doi.org/10.1124/jpet.113.203257

  3. Jain, Arjun

    1. Endothelin-1–Induced Endoplasmic Reticulum Stress in Disease
      Arjun Jain
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 163-172; DOI: https://doi.org/10.1124/jpet.113.205567

  4. Jane, Esther P.

    1. Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor– Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway
      Daniel R. Premkumar, Esther P. Jane, Kimberly A. Foster and Ian F. Pollack
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 201-210; DOI: https://doi.org/10.1124/jpet.113.204743

  5. Janes, Julie

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  6. Jaw-Tsai, S.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

  7. Ji, Shundong

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  8. Ji, Y.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

  9. Jin, Ping

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  10. Johnson, Randolph M.

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  11. Jungck, David

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

K

  1. Karim, Felix

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  2. Karp, Russell

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  3. Kleinau, Gunnar

    1. Selective and Potent Agonists and Antagonists for Investigating the Role of Mouse Oxytocin Receptors
      Marta Busnelli, Elisabetta Bulgheroni, Maurice Manning, Gunnar Kleinau and Bice Chini
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 318-327; DOI: https://doi.org/10.1124/jpet.113.202994

  4. Knobloch, Jürgen

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

  5. Koch, Andrea

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

  6. Kohan, Donald E.

    1. Myocardial, Smooth Muscle, Nephron, and Collecting Duct Gene Targeting Reveals the Organ Sites of Endothelin A Receptor Antagonist Fluid Retention
      Deborah Stuart, Mark Chapman, Sara Rees, Stephanie Woodward and Donald E. Kohan
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 182-189; DOI: https://doi.org/10.1124/jpet.113.205286

L

  1. Labenski, Matthew T.

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  2. Lappe, Rodney W.

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  3. Laruelle, Marc

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  4. Levin, Nancy

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  5. Li, Lingna

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  6. Liu, Qiang

    1. Protective Properties of 2-Acetylcyclopentanone in a Mouse Model of Acetaminophen Hepatotoxicity
      Lihai Zhang, Terrence Gavin, Brian C. Geohagen, Qiang Liu, Katherine J. Downey and Richard M. LoPachin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 259-269; DOI: https://doi.org/10.1124/jpet.113.205435

  7. Liu, Shuang

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  8. LoPachin, Richard M.

    1. Protective Properties of 2-Acetylcyclopentanone in a Mouse Model of Acetaminophen Hepatotoxicity
      Lihai Zhang, Terrence Gavin, Brian C. Geohagen, Qiang Liu, Katherine J. Downey and Richard M. LoPachin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 259-269; DOI: https://doi.org/10.1124/jpet.113.205435

  9. Lounsbury, Heather

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  10. Lu, Yun-Bi

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  11. Luo, Yanping

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

M

  1. Maclean, Derek

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  2. Maillard, Marc

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

  3. Manning, Maurice

    1. Selective and Potent Agonists and Antagonists for Investigating the Role of Mouse Oxytocin Receptors
      Marta Busnelli, Elisabetta Bulgheroni, Maurice Manning, Gunnar Kleinau and Bice Chini
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 318-327; DOI: https://doi.org/10.1124/jpet.113.202994

  4. Martin, W. J.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

  5. Marzano, Carmine

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  6. Mash, Eugene A.

    1. Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2
      Mathew Belzer, Mark Morales, Bhumasamudram Jagadish, Eugene A. Mash and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 300-310; DOI: https://doi.org/10.1124/jpet.113.203257

  7. Matin, Marla J.

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  8. Mazdiyasni, Hormoz

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  9. McFadden, Lisa M.

    1. Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat
      Glen R. Hanson, Amanda J. Hoonakker, Christina M. Robson, Lisa M. McFadden, Paul S. Frankel and Mario E. Alburges
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 173-181; DOI: https://doi.org/10.1124/jpet.113.205310

  10. McNamara, A.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

  11. Mendel, Dirk B.

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  12. Mi, Zaichuan

    1. In Vivo Cardiovascular Pharmacology of 2′,3′-cAMP, 2′-AMP, and 3′-AMP in the Rat
      Edwin K. Jackson and Zaichuan Mi
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 190-200; DOI: https://doi.org/10.1124/jpet.113.205757

  13. Morales, Mark

    1. Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2
      Mathew Belzer, Mark Morales, Bhumasamudram Jagadish, Eugene A. Mash and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 300-310; DOI: https://doi.org/10.1124/jpet.113.203257

  14. Mordasini, David

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

  15. Mudd, Sarah R.

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

N

  1. Nacht, Mariana

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  2. Neve, Marta

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  3. Nielsen, Peter Aadal

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

O

  1. Obedencio, G. P.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

  2. Ogilvie, Kathleen

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  3. Olsen, Line Rørbæk

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

  4. Osothprarop, Trina F.

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

P

  1. Palanki, Moorthy

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  2. Peregaux, Christine

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

  3. Petrone, Marcella

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  4. Petter, Russell C.

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  5. Phan, Olivier

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

  6. Pollack, Ian F.

    1. Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor– Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway
      Daniel R. Premkumar, Esther P. Jane, Kimberly A. Foster and Ian F. Pollack
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 201-210; DOI: https://doi.org/10.1124/jpet.113.204743

  7. Premkumar, Daniel R.

    1. Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor– Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway
      Daniel R. Premkumar, Esther P. Jane, Kimberly A. Foster and Ian F. Pollack
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 201-210; DOI: https://doi.org/10.1124/jpet.113.204743

  8. Pulido-Rios, M. T.

    1. In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
      M. T. Pulido-Rios, A. McNamara, G. P. Obedencio, Y. Ji, S. Jaw-Tsai, W. J. Martin and S. S. Hegde
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 241-250; DOI: https://doi.org/10.1124/jpet.113.203554

R

  1. Rabiner, Eugenii A.

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  2. Rees, Sara

    1. Myocardial, Smooth Muscle, Nephron, and Collecting Duct Gene Targeting Reveals the Organ Sites of Endothelin A Receptor Antagonist Fluid Retention
      Deborah Stuart, Mark Chapman, Sara Rees, Stephanie Woodward and Donald E. Kohan
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 182-189; DOI: https://doi.org/10.1124/jpet.113.205286

  3. Retting, Kelsey

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  4. Robson, Christina M.

    1. Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat
      Glen R. Hanson, Amanda J. Hoonakker, Christina M. Robson, Lisa M. McFadden, Paul S. Frankel and Mario E. Alburges
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 173-181; DOI: https://doi.org/10.1124/jpet.113.205310

  5. Rolzin, Paul

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

S

  1. Salinas, Cristian A.

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  2. Shao, Guoqiang

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  3. Sheets, Michael

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  4. Shi, Qiao-Juan

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  5. Shotbolt, Paul

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  6. Singh, Juswinder

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  7. Slifstein, Mark

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  8. Stehle, Jean-Christophe

    1. PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
      Olivier Phan, Marc Maillard, Christine Peregaux, David Mordasini, Jean-Christophe Stehle, Felix Funk and Michel Burnier
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 281-289; DOI: https://doi.org/10.1124/jpet.113.204792

  9. Stoelben, Erich

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

  10. Stuart, Deborah

    1. Myocardial, Smooth Muscle, Nephron, and Collecting Duct Gene Targeting Reveals the Organ Sites of Endothelin A Receptor Antagonist Fluid Retention
      Deborah Stuart, Mark Chapman, Sara Rees, Stephanie Woodward and Donald E. Kohan
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 182-189; DOI: https://doi.org/10.1124/jpet.113.205286

  11. Svenstrup, Niels

    1. The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
      Olga Andersson, Steen Honoré Hansen, Karin Hellman, Line Rørbæk Olsen, Gunnar Andersson, Lassina Badolo, Niels Svenstrup and Peter Aadal Nielsen
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 211-218; DOI: https://doi.org/10.1124/jpet.113.205476

T

  1. Talukdar, Saswata

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  2. Tester, Richland

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  3. Tomlinson, James E.

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

V

  1. Van der Aart, Jasper

    1. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
      Robert A. Comley, Cristian A. Salinas, Mark Slifstein, Marcella Petrone, Carmine Marzano, Idriss Bennacef, Paul Shotbolt, Jasper Van der Aart, Marta Neve, Laura Iavarone, Roberto Gomeni, Marc Laruelle, Frank A. Gray, Roger N. Gunn and Eugenii A. Rabiner
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 311-317; DOI: https://doi.org/10.1124/jpet.112.202895

  2. Violand, Bernard N.

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  3. Voorbach, Martin J.

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

W

  1. Wahl, Chiara

    1. Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin
      Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 290-299; DOI: https://doi.org/10.1124/jpet.112.202358

  2. Walter, Sarah

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  3. Wang, Xiao-Rong

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  4. Wei, Er-Qing

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  5. Westlin, William F.

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  6. Witowski, Steven R.

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489

  7. Woodnutt, Gary

    1. Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
      Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420

  8. Woodward, Stephanie

    1. Myocardial, Smooth Muscle, Nephron, and Collecting Duct Gene Targeting Reveals the Organ Sites of Endothelin A Receptor Antagonist Fluid Retention
      Deborah Stuart, Mark Chapman, Sara Rees, Stephanie Woodward and Donald E. Kohan
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 182-189; DOI: https://doi.org/10.1124/jpet.113.205286

  9. Wright, Stephen H.

    1. Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2
      Mathew Belzer, Mark Morales, Bhumasamudram Jagadish, Eugene A. Mash and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 300-310; DOI: https://doi.org/10.1124/jpet.113.203257

X

  1. Xu, Dong-Min

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

Y

  1. Yin, Qun

    1. Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
      Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834

  2. Yu, Shu-Ying

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

Z

  1. Zhang, Li-Hui

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  2. Zhang, Lihai

    1. Protective Properties of 2-Acetylcyclopentanone in a Mouse Model of Acetaminophen Hepatotoxicity
      Lihai Zhang, Terrence Gavin, Brian C. Geohagen, Qiang Liu, Katherine J. Downey and Richard M. LoPachin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 259-269; DOI: https://doi.org/10.1124/jpet.113.205435

  3. Zhang, Wei-Ping

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  4. Zhang, Xia-Yan

    1. HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
      Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604

  5. Zhang, Yumin

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  6. Zhou, Yang

    1. Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2
      Shundong Ji, Yang Zhou, Martin J. Voorbach, Guoqiang Shao, Yumin Zhang, Gerard B. Fox, Daniel H. Albert, Yanping Luo, Shuang Liu and Sarah R. Mudd
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 251-258; DOI: https://doi.org/10.1124/jpet.112.202622

  7. Zhu, Zhendong

    1. Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
      Erica K. Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T. Labenski, Steven R. Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I. Freed, Russell C. Petter, Alex Dubrovskiy, Juswinder Singh and William F. Westlin
      Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 219-228; DOI: https://doi.org/10.1124/jpet.113.203489
Back to top

In this issue

Advertisement